Aldosterone, cognitive function, and cerebral hemodynamics in hypertension and antihypertensive therapy

American Journal of Hypertension

Volumn 28, Issue 3, 2015, Pages 319-325

  Hajjar, Ihab ^a   Hart, Meaghan ^b   MacK, Wendy ^c   Lipsitz, Lewis A ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hebrew Senior Life   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aldosterone; Blood flow velocity hypertension; Blood pressure; Cognition; Renin; Vasoreactivity

Indexed keywords

ALDOSTERONE; CANDESARTAN; CARBON DIOXIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; RENIN; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTOREGULATION; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; COGNITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEMORY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SYSTOLIC BLOOD PRESSURE; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; TREATMENT DURATION; BLOOD; BRAIN CIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY;

AGED; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; BIOMARKERS; CEREBROVASCULAR CIRCULATION; COGNITION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RENIN;

EID: 84983268880     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu161     Document Type: Article

References (34)

1. Diz DI, Kasper SO, Sakima A, Ferrario CM. Aging and the brain reninangiotensin system: insights from studies in transgenic rats. Cleve Clin J Med 2007; 74 Suppl 1:S95-98.
2. Savaskan E. The role of the brain renin-angiotensin system in neurodegenerative disorders. Curr Alzheimer Res 2005; 2:29-35.
3. Wright JW, Harding JW. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch 2013; 465:133-151.
4. Bonini JS, Bevilaqua LR, Zinn CG, Kerr DS, Medina JH, Izquierdo I, Cammarota M. Angiotensin II disrupts inhibitory avoidance memory retrieval. Horm Behav 2006; 50:308-313.
5. Kazama K, Wang G, Frys K, Anrather J, Iadecola C. Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. Am J Physiol Heart Circ Physiol 2003; 285:H1890-H1899.
6. Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M. Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 2009; 53:356-362.
7. Hajjar I, Keown M, Frost B. Antihypertensive agents for aging patients who are at risk for cognitive dysfunction. Curr Hypertens Rep 2005; 7:466-473.
8. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351:33-41.
9. Vasan RS, Demissie S, Kimura M, Cupples LA, Rifai N, White C, Wang TJ, Gardner JP, Cao X, Benjamin EJ, Levy D, Aviv A. Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study. Circulation 2008; 117:1138-1144.
10. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol 2009; 297:F559-F576.
11. Hashikabe Y, Suzuki K, Jojima T, Uchida K, Hattori Y. Aldosterone impairs vascular endothelial cell function. J Cardiovasc Pharmacol 2006; 47:609-613.
12. Farquharson CA, Struthers AD. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond) 2002; 103:425-431.
13. Umemura T, Kawamura T, Umegaki H, Mashita S, Kanai A, Sakakibara T, Hotta N, Sobue G. Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 2011; 82:1186-1194.
14. Ainslie PN, Murrell C, Peebles K, Swart M, Skinner MA, Williams MJ, Taylor RD. Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function. Exp Physiol 2007; 92:769-777.
15. Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J 2010; 10:46-53.
16. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95:948-953.
17. Hajjar I, Kritchevsky S, Newman AB, Li R, Yaffe K, Simonsick EM, Lipsitz LA. Renin angiotensin system gene polymorphisms modify angiotensin-converting enzyme inhibitors' effect on cognitive function: the health, aging and body composition study. J Am Geriatr Soc 2010; 58:1035-1042.
18. Hajjar I, Hart M, Milberg W, Novak V, Lipsitz L. The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition. BMC Geriatr 2009; 9:48.
19. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45:142-161.
20. McKenzie JK, Clements JA. Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab 1974; 38:622-627.
21. Hetzel A, Braune S, Guschlbauer B, Dohms K. CO2 reactivity testing without blood pressure monitoring? Stroke 1999; 30:398-401.
22. Ringelstein EB, Sievers C, Ecker S, Schneider PA, Otis SM. Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke 1988; 19:963-969.
23. Bishop CC, Powell S, Insall M, Rutt D, Browse NL. Effect of internal carotid artery occlusion on middle cerebral artery blood flow at rest and in response to hypercapnia. Lancet 1986; 1:710-712.
24. Claassen JA, Zhang R, Fu Q, Witkowski S, Levine BD. Transcranial Doppler estimation of cerebral blood flow and cerebrovascular conductance during modified rebreathing. J Appl Physiol 2007; 102:870-877.
25. Kronmal RA. Spurious correlation and the fallacy of the ratio standard revisited. J R Stat Soc Ser A Stat Soc 1993; 156:379-392.
26. Hajjar I, Hart M, Chen YL, Mack W, Novak V, C Chui H, Lipsitz L. Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial. J Am Geriatr Soc 2013; 61:194-201.
27. Gomez-Sanchez EP, Gomez-Sanchez CM, Plonczynski M, Gomez-Sanchez CE. Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension. Exp Physiol 2010; 95:120-130.
28. Peysner K, Henry CA, Malvin RL. Central infusion of aldosterone increases blood pressure by mechanisms independent of Na retention. Clin Exp Hypertens A 1990; 12:399-414.
29. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals. Arterioscler Thromb Vasc Biol 2006; 26:826-832.
30. Scheuer DA. Stimulation of aldosterone synthesis by angiotensin II in the brain: support for positive feedback in hypertension? Hypertension 2013; 62:459-460.
31. Geerling JC, Kawata M, Loewy AD. Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol 2006; 494:515-527.
32. Pardridge WM, Mietus LJ. Regional blood-brain barrier transport of the steroid hormones. J Neurochem 1979; 33:579-581.
33. Pietranera L, Brocca ME, Cymeryng C, Gomez-Sanchez E, Gomez-Sanchez CE, Roig P, Lima A, De Nicola AF. Increased expression of the mineralocorticoid receptor in the brain of spontaneously hypertensive rats. J Neuroendocrinol 2012; 24:1249-1258.
34. Oberleithner H. Aldosterone makes human endothelium stiff and vulnerable. Kidney Int 2005; 67:1680-1682.